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Abstract Little evidence exists about the incidence of
deep vein thrombosis (DVT) and pulmonary embolism
(PE) with the use of external fixators. We investigated this
in a cohort of 207 consecutive patients undergoing 258
elective frame applications by case note review. Case notes
were obtained for 84 % of the sample population. The type
of surgery, demographic data, thromboembolic risk factors
and the incidence of DVT/PE were recorded. One patient
experienced DVT (0.39 %) and one a PE (0.39 %). Both
were of high risk and had received mechanical and che-
mical thromboprophylaxis during their inpatient stay.
These complications were identified at least 3 months post-
operatively. These findings help to more accurately counsel
patients undergoing elective frame surgery on the risks of
DVT/PE and also contribute to the discussion between
surgeons about whether or not extended course chemical
thromboprophylaxis would be of overall benefit.
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Introduction
Deep vein thrombosis (DVT) and pulmonary embolism
(PE) are potential complications of lower limb ortho-
paedic surgery, and reported rates vary widely (DVT
0.33–0.40 %, PE 0.04–0.22 %) [1, 2, 5, 7]. Little evi-
dence exists about the incidence of DVT and PE with the
use of external fixators. Sems et al. [3] reported that 3 of
143 (2.1 %) patients screened with duplex ultrasonogra-
phy following frame application for the temporary sta-
bilisation of complex lower limb fractures were found to
have a DVT.
The National Institute of Health and Clinical Excel-
lence (NICE) provides guidance for thromboprophylaxis
in orthopaedic surgery with specific recommendations
for hip and knee arthroplasty and for hip fractures.
Chemical thromboprophylaxis is recommended for
28–35 days for hip arthroplasty and following hip frac-
ture surgery and 10–14 days following knee replace-
ment. For other forms of orthopaedic surgery besides hip
and knee arthroplasty and hip fracture surgery NICE
recommends that individual patients should be assessed
for thrombotic risk factors and chemical thrombopro-
phylaxis given if risk factors for DVT/PE are present
[4].
No published work exists regarding DVT/PE incidence
with the elective use of external fixators. The aim of this
work is to establish the rate of DVT/PE in those under-
going elective treatment with external fixators in our
practice.
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Materials and methods
At the Royal National Orthopaedic Hospital, Stanmore,
external fixators are used for elective surgery such as pae-
diatric, adolescent and adult deformity correction and for
treatment of fracture non-union. Thromboprophylaxis use is
guided by the risk of thromboembolism and risk of bleeding
in these cases with chemical thromboprophylaxis used only
for individuals considered to be at high risk of thrombosis.
A database of individuals undergoing external fixator
application by the senior authors is maintained prospectively.
Information from this database and case notes were exam-
ined for consecutive patients from March 2005 to June 2011.
Occurrences of post-operative DVT or PE detected by
ultrasound or CT angiogram were recorded. Risk factors for
thromboembolism, type of thromboprophylaxis and time
from end surgery to first dose of chemical thromboprophy-
laxis were also noted. Patient demographics (age, weight
and height), indication for surgery, operation performed and
length of operation were recorded. The length of operation
was calculated as the period between the first incision of the
surgeon and the time the patient left the operating theatre,
both noted on the perioperative care record by theatre
nursing staff. Although the time of surgeon completing the
operation was not recorded, we considered our measure of
length of operation time to be an acceptable estimate as the
time between completion of surgery and the patient leaving
operating theatre is typically five minutes or less.
Patients are counselled in clinic pre-operatively by a
specialist nurse about practical and social aspects of un-
dergoing treatment with an external fixator. The use of
thromboprophylaxis in all cases was decided on individual
risk factor assessment balanced with risk of bleeding.
Where appropriate, a compression stocking and an intra-
operative calf pump were used on the contralateral leg
before, during and after surgery. Long surgical time as an
isolated risk factor is not considered an indication for using
chemical thromboprophylaxis by a senior author (PC).
Mobilisation was commenced the morning after surgery
and the majority of patients were permitted to bear weight
fully as symptoms allowed.
The application of the external fixator was performed
under general anaesthetic and fluoroscopic guidance with-
out use of a tourniquet. Osteotomies, where needed, were
made through small open incisions with multiple drill holes
and completed in a controlled manner with an osteotome.
Results
Two hundred and seven patients underwent 258 consecutive
primary applications of an Ilizarov, Taylor Spatial Frame
(TSF) or monolateral fixator by one of the senior authors
(PC) in the study period. Data including the age of patient,
indication for surgery, bone to which the frame was applied
and type of fixator were available for all patients from the
electronic database (Figs. 1, 2, 3, 4). Case notes were ob-
tained for 176 individuals (84 %), representing 217 frame
applications (85 %). In nine cases frames for correction of
clubfoot deformity involved pins or wires in the foot with a
frame bridging and immobilising the ankle. If an individual
had bilateral application of external fixators under the same
anaesthetic it was considered as two separate frame appli-
cation events. We found no bleeding complications.
Two individuals were affected by DVT or PE. One had a
DVT and one a PE, an overall isolated DVT rate of 1/258
(0.39 %) and PE rate of 1/258 (0.39 %). Considering only
individuals aged 16 and older, the DVT rate was 1/183
(0.55 %) and PE 1/183 (0.55 %). In both cases, mechanical
and chemical prophylaxis had been used.
Case 1
A 43-year-old male smoker was diagnosed with non-union
of a femoral shaft fracture. The fracture was sustained in
July 2008 and managed with intramedullary nail fixation.
For the non-union he had an unsuccessful revision nailing
and subsequent drilling with bone marrow injection. In
February 2009 the nail was removed and plate fixation with
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Fig. 2 Indications for surgery
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Implants were removed and a unilateral external fixator
was applied in January 2011 to correct shortening of the
femur. He developed a DVT in April 2011 while the fixator
was still in situ. He subsequently developed some symp-
toms of a post-phlebitic limb.
Case 2
A 44-year-old male smoker of high BMI with a diagnosis
of recurrent adamantinoma underwent excision of the
lateral tibial cortex tumour and medullary curettage in
April 2010. Due to a recurrence in November 2010, a
segmental diaphyseal excision and application of a TSF
was performed for bone transport. In the last month of a
4-month course of frame treatment he experienced a PE
with symptoms of mild shortness of breath which fully
resolved. Of note, this man was resident overseas and
throughout the course of his frame treatment made several
flights of over 3 h between the UK and his home.
Other than surgical time (Fig. 5), 47 individuals had
one risk factor, six had two, and three patients had
three. Risk factors are summarised in Table 1.
Of the procedures for which records were obtained,
patients received post-operative prophylactic dose low
molecular weight heparin (LMWH) for 71 procedures.
Forty of those who received LMWH had identifiable risk
factors on review of case notes. Of the 31 without an
identified risk factor, we have postulated the potential
reason for the use of chemical thromboprophylaxis which
is summarised in Table 2. If the first dose of chemical
prophylaxis was more than 36 h post-operatively, the use
of LMWH was thought to be due to prolonged immobility.
For those with insufficient data to calculate a BMI, it was
surmised that this was the risk factor for which LMWH
was used. One individual had polio and another who un-
derwent simultaneous application of an ipsilateral femoral
and tibial frame may have been considered to be risks of
thromboembolism.
Twenty patients were found to have risk factors for
thrombosis but were not treated with chemical thrombo-
prophylaxis, summarised in Table 3. Of 12 adults with high
BMI, only three had a BMI over 40; four whose only risk
factor was age[ 60 were aged between 62 and 66. These
cases of patients with a BMI and age close to the threshold
of a risk of thrombotic event may not have had their risk





















































































Fig. 5 Length of procedure
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Subsequent to this study population, there have been two
further cases of DVT/PE in patients treated with external
fixators by the senior authors. These cases were not in-
cluded in the above data, but their histories are included
below (Cases 3 and 4) to help inform further discussion.
Case 3
A 53-year-old man with knee osteoarthritis secondary to
malunion of a proximal tibial fracture sustained at age 26
underwent application of a Taylor Spatial Frame for de-
formity correction in November 2012. The frame was re-
moved in March 2013. Three weeks after frame removal,
calf swelling prompted an investigation and a DVT was
found. Following a course of anticoagulant treatment he
has no residual symptoms.
Case 4
A 30-year-old male smoker was treated with a unilateral
fixator to lengthen a malunited femoral shaft fracture,
which had been sustained with other injuries in a traffic
collision in August 2011. He developed multiple pul-
monary emboli and respiratory symptoms for 3 days fol-
lowing osteotomy and application of fixator in October
2012. His symptoms fully resolved. It was noted that he
had reduced mobility due to his accompanying injuries.
Discussion
The incidence of clinically significant DVT has been re-
ported from 0.33 to 40 % with fatal PE 0.04–0.22 % in hip
and knee arthroplasty [1, 2, 5, 6]. The incidence of DVT
detected by screening with venogram or duplex ultrasound
has been reported between 30 and 56 % [7, 8]. The work
by Sems et al. [3] involved investigating all patients with
duplex ultrasound following application of an external
fixator as a temporary measure (2–3 weeks) in severe lower
limb fractures. They found that 3 of 143 (2.1 %) patients
screened with duplex ultrasonography following frame
application were found to have a DVT. No bleeding
complications from chemical thromboprophylaxis were
experienced. This information has limited applicability to
elective practice as external fixators were used in short-
term stabilisation compared with the significantly longer-
term use in elective surgical practice. Furthermore, trauma
results in additional prothrombotic risks such as a high-
energy insult to the limb, haemodynamic changes with its
effect on coagulation and greater short-term immobility
due to other injuries.
Efforts continue at our hospital to optimise thrombo-
prophylaxis including optimal patient hydration, the use of
mechanical thromboprophylaxis and optimal post-op-
erative pain control to enable early mobilisation. One
limitation of mechanical thromboprophylaxis in this group
of patients is that the use of TEDS or intermittent com-
pression stockings is impossible on the operated leg.
Towards the end of our study period, a local Thrombo-
prophylaxis Risk Assessment Prescribing Guide came into
use and alternative tools for adolescents and children have
been developed and are now used.
Limitations of this study are the retrospective collection
of a significant proportion of the data, resulting in some
cases of missing data. Of particular note, our postulated
reasons for using chemical prophylaxis in the absence of
identifiable risk factors as well as for not prescribing it for
those with risk factors contribute to weakness of our data
and analysis. Further confounding was from the chemical
thromboprophylaxis prescription guided by individual pa-
tient factors, with some individuals given low molecular
weight heparin and others not. Even so, there remains a
lack of strong evidence for the routine use of chemical
thromboprophylaxis in orthopaedic practice with a lack of
Table 1 Risk factors for DVT/PE in our population
Risk factor Incidence
Obesity (BMI[ 30) 48
Previous DVT/PE 4
Recent travel over 2 h 1
Age 60 or greater 12
Thrombophilia 1
Recent/active cancer 2
Table 2 Summary of risk factors in patients treated with low mole-
cular weight heparin (LMWH)
Those with thrombotic risk factors treated with LMWH 40
Those with no thrombotic risk factors treated with LMWH 31
Postulateda reason for LMWH treatment in those with no recorded
risk factors
Prolonged post-operative immobility 9
High BMI 10
Polio 1
No reason identified 11
a Following review of patient records
Table 3 Those individuals with risk factors for thrombosis not
treated with LMWH
High BMI 12
High BMI, under 16 years old 3
Age over 60 4
High BMI and age over 60 1
Total 20
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consensus [4, 9, 10]. The aim of this work was to provide
information in elective external fixator surgery to allow
surgeons to inform patients of the risks of DVT and PE in
this surgery and to highlight the need for further research
and discussion between clinicians about appropriate
thromboprophylactic regimes.
The two patients in our study population did not become
symptomatic with DVT or PE until 3 months post-op-
eratively although it is not possible to know when the clots
began, whether at the time of surgery or months after
discharge from hospital. One of the two additional pre-
sented cases outside our study population (Case 3) also
experienced such a delay in presentation. Therefore, if an
extended course chemical thromboprophylaxis was to be
used in high-risk patients, these findings suggest that it
would be required for at least 3 months. Although the
number of patients in our study means it is one of the
largest studies of DVT and PE in elective frame surgery,
these numbers are insufficient for it to provide conclusive
guidance on extended course. Larger studies are required.
Conclusion
A thromboembolic event was identified in two patients
from a sample of 258 fixator applications in 207 patients.
This produces an incidence of approximately 1 % of pa-
tients undergoing fixator surgery. Due to the heterogeneous
manner in which prophylaxis was used, no specific con-
clusions can be made over the protection given by chemical
or mechanical thromboprophylaxis.
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